SHL Telemedicine Ltd. Statistics
Share Statistics
SHL Telemedicine Ltd. has 16.39M shares outstanding. The number of shares has increased by 6.76% in one year.
| Shares Outstanding | 16.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 12.74M |
| Failed to Deliver (FTD) Shares | 1.08K |
| FTD / Avg. Volume | 5.98% |
Short Selling Information
The latest short interest is 3.64K, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 3.64K |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 0.98 |
Valuation Ratios
The PE ratio is -14.68 and the forward PE ratio is -10.58.
| PE Ratio | -14.68 |
| Forward PE | -10.58 |
| PS Ratio | 1.82 |
| Forward PS | 0.6 |
| PB Ratio | 1.41 |
| P/FCF Ratio | -14.86 |
| PEG Ratio | n/a |
Enterprise Valuation
SHL Telemedicine Ltd. has an Enterprise Value (EV) of 239.13M.
| EV / Earnings | -33.89 |
| EV / Sales | 4.19 |
| EV / EBITDA | 72.83 |
| EV / EBIT | -26.55 |
| EV / FCF | -34.31 |
Financial Position
The company has a current ratio of 2.3, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.3 |
| Quick Ratio | 2.1 |
| Debt / Equity | 0.17 |
| Total Debt / Capitalization | 14.65 |
| Cash Flow / Debt | -0.12 |
| Interest Coverage | -5.77 |
Financial Efficiency
Return on equity (ROE) is -0.1% and return on capital (ROIC) is -10.75%.
| Return on Equity (ROE) | -0.1% |
| Return on Assets (ROA) | -0.06% |
| Return on Capital (ROIC) | -10.75% |
| Revenue Per Employee | 97.90K |
| Profits Per Employee | -12.10K |
| Employee Count | 583 |
| Asset Turnover | 0.5 |
| Inventory Turnover | 9.2 |
Taxes
| Income Tax | 891.00K |
| Effective Tax Rate | -0.15 |
Stock Price Statistics
The stock price has increased by -67.45% in the last 52 weeks. The beta is 0.4, so SHL Telemedicine Ltd.'s price volatility has been higher than the market average.
| Beta | 0.4 |
| 52-Week Price Change | -67.45% |
| 50-Day Moving Average | 2.86 |
| 200-Day Moving Average | 4.49 |
| Relative Strength Index (RSI) | 58.39 |
| Average Volume (20 Days) | 18.10K |
Income Statement
In the last 12 months, SHL Telemedicine Ltd. had revenue of $57.08M and earned -$7.06M in profits. Earnings per share was $-0.54.
| Revenue | 57.08M |
| Gross Profit | 25.26M |
| Operating Income | -9.01M |
| Net Income | -7.06M |
| EBITDA | 3.28M |
| EBIT | -9.01M |
| Earnings Per Share (EPS) | -0.54 |
Balance Sheet
The company has $6.69M in cash and $19.86M in debt, giving a net cash position of -$13.17M.
| Cash & Cash Equivalents | 6.69M |
| Total Debt | 19.86M |
| Net Cash | -13.17M |
| Retained Earnings | -80.13M |
| Total Assets | 102.84M |
| Working Capital | 17.88M |
Cash Flow
In the last 12 months, operating cash flow was -$1.50M and capital expenditures -$5.48M, giving a free cash flow of -$6.97M.
| Operating Cash Flow | -1.50M |
| Capital Expenditures | -5.48M |
| Free Cash Flow | -6.97M |
| FCF Per Share | -0.54 |
Margins
Gross margin is 44.26%, with operating and profit margins of -15.78% and -12.36%.
| Gross Margin | 44.26% |
| Operating Margin | -15.78% |
| Pretax Margin | -10.45% |
| Profit Margin | -12.36% |
| EBITDA Margin | 5.75% |
| EBIT Margin | -15.78% |
| FCF Margin | -12.21% |
Dividends & Yields
SHLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -19.49% |
| FCF Yield | -15.35% |
Analyst Forecast
The average price target for SHLT is $11, which is 297.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $11 |
| Price Target Difference | 297.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 0.33 |
| Piotroski F-Score | 4 |